Why is Jagsonpal Pharma falling/rising?

As of 01-Aug, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 271.15, which reflects a decrease of Rs 14.3 or 5.01%. Today's performance indicates that the stock underperformed its sector by 1.85%, with an intraday low of Rs 270.1, marking a drop of 5.38%. Despite a strong long-term performance, with a 77.11% return over the past year and a remarkable 1887.90% increase over five years, the stock has faced recent selling pressure, evidenced by a significant drop in delivery volume by 61.33% against the five-day average. The stock remains above its longer-term moving averages but is below its five-day moving average, suggesting a short-term weakness.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has declined by 1.06% over the past week. While Jagsonpal Pharmaceuticals has shown resilience with an 18.93% increase over the past month, the current downturn may be influenced by the overall decline in the Pharmaceuticals & Drugs sector, which has fallen by 3.27%. The company's strong fundamentals, including a low debt-to-equity ratio and consistent positive results over the last five quarters, indicate potential for recovery, but the current market sentiment and reduced investor participation are likely contributing to the stock's recent price decline.